BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30285867)

  • 41. Are idiopathic pulmonary fibrosis patients more anxious and depressive than patient's with other interstitial lung disease?
    Yalnız E; Polat G; Demirci F; Deniz S; Karadeniz G; Aydınlı E; Vayisoglu G; Ayrancı A
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(4):294-301. PubMed ID: 32476965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
    Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
    PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
    Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study.
    Yoo H; Jeong BH; Chung MJ; Lee KS; Kwon OJ; Chung MP
    BMC Pulm Med; 2019 Aug; 19(1):149. PubMed ID: 31412851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe.
    Karampitsakos T; Spagnolo P; Mogulkoc N; Wuyts WA; Tomassetti S; Bendstrup E; Molina-Molina M; Manali ED; Unat ÖS; Bonella F; Kahn N; Kolilekas L; Rosi E; Gori L; Ravaglia C; Poletti V; Daniil Z; Prior TS; Papanikolaou IC; Aso S; Tryfon S; Papakosta D; Tzilas V; Balestro E; Papiris S; Antoniou K; Bouros D; Wells A; Kreuter M; Tzouvelekis A
    Respirology; 2023 Jan; 28(1):56-65. PubMed ID: 36117239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement.
    Gjonbrataj J; Choi WI; Bahn YE; Rho BH; Lee JJ; Lee CW
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):742-6. PubMed ID: 25946370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical features of patients with small cell lung cancer and idiopathic pulmonary fibrosis treated with chemotherapy or chemoradiotherapy.
    Kanaji N; Shimizu J; Sakai K; Ueda Y; Miyawaki H; Watanabe N; Uemura T; Hida T; Inoue T; Watanabe N; Oohara Y; Dobashi H; Kato M; Kadowaki N
    Ther Adv Respir Dis; 2020; 14():1753466620963866. PubMed ID: 33086985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.
    Douglas D; Keating L; Strykowski R; Lee CT; Garcia N; Selvan K; Kaushik N; Bauer Ventura I; Jablonski R; Vij R; Chung JH; Bellam S; Strek ME; Adegunsoye A
    Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L233-L243. PubMed ID: 37366539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis.
    Khan KA; Kennedy MP; Moore E; Crush L; Prendeville S; Maher MM; Burke L; Henry MT
    Lung; 2015 Feb; 193(1):71-7. PubMed ID: 25381634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serial perfusion in native lungs in patients with idiopathic pulmonary fibrosis and other interstitial lung diseases after single lung transplantation.
    Sokai A; Handa T; Chen F; Tanizawa K; Aoyama A; Kubo T; Ikezoe K; Nakatsuka Y; Oguma T; Hirai T; Nagai S; Chin K; Date H; Mishima M
    Clin Transplant; 2016 Apr; 30(4):407-14. PubMed ID: 26780970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.
    Tzouvelekis A; Karampitsakos T; Gomatou G; Bouros E; Tzilas V; Manali E; Tomos I; Trachalaki A; Kolilekas L; Korbila I; Tomos P; Chrysikos S; Gaga M; Daniil Z; Bardaka F; Papanikolaou IC; Euthymiou C; Papakosta D; Steiropoulos P; Ntolios P; Tringidou R; Papiris S; Antoniou K; Bouros D
    Pulm Pharmacol Ther; 2020 Feb; 60():101880. PubMed ID: 31874284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
    Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).
    Krauss E; Gehrken G; Drakopanagiotakis F; Tello S; Dartsch RC; Maurer O; Windhorst A; von der Beck D; Griese M; Seeger W; Guenther A
    BMC Pulm Med; 2019 Jul; 19(1):130. PubMed ID: 31319833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clustering of lung diseases in the family of interstitial lung disease patients.
    Terwiel M; Grutters JC; van Moorsel CHM
    BMC Pulm Med; 2022 Apr; 22(1):134. PubMed ID: 35392870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IPF, comorbidities and management implications.
    Vancheri C; Cottin V; Kreuter M; Hilberg O
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():17-23. PubMed ID: 26237439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronary artery disease and heart failure in patients with idiopathic pulmonary fibrosis.
    Kato S; Kitamura H; Hayakawa K; Fukui K; Tabata E; Otoshi R; Iwasawa T; Utsunomiya D; Kimura K; Tamura K; Ogura T
    Heart Vessels; 2021 Aug; 36(8):1151-1158. PubMed ID: 33486554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases.
    King C; Nathan SD
    Curr Opin Pulm Med; 2013 Sep; 19(5):466-73. PubMed ID: 23912191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.
    Takei R; Brown KK; Yamano Y; Kataoka K; Yokoyama T; Matsuda T; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Goto Y; Kondoh Y
    Respirology; 2022 May; 27(5):333-340. PubMed ID: 35293077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015.
    Pedraza-Serrano F; Jiménez-García R; López-de-Andrés A; Hernández-Barrera V; Sánchez-Muñoz G; Puente-Maestu L; de-Miguel-Díez J
    Medicine (Baltimore); 2019 May; 98(21):e15779. PubMed ID: 31124970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.